Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine)

被引:87
作者
Mahato, RI [1 ]
Takemura, S [1 ]
Akamatsu, K [1 ]
Nishikawa, M [1 ]
Takakura, Y [1 ]
Hashida, M [1 ]
机构
[1] KYOTO UNIV, FAC PHARMACEUT SCI, DEPT DRUG DELIVERY RES, SAKYO KU, KYOTO 60601, JAPAN
关键词
oligonucleotides; pharmacokinetics; hepatic uptake; particle size; zeta potential; macrophage;
D O I
10.1016/S0006-2952(96)00880-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition characteristics of a 20 mer antisense phosphodiester oligonucleotide (PO) and its fully phosphorothioated derivative (PS) alone or complexed with glycosylated poly(L-lysine) (galactosylated polylysine, Gal-PLL; mannosylated polylysine, Man-PLL) were studied in mice in relation to their physicochemical characteristics. Good complex formation was obtained at a ratio of 1:0.6, w/w [oligonucleotides (ODNs)/carrier]. The 1:0.6 weight ratio of ODNs/Gal-PLL and ODNs/Man-PLL complexes had zeta potentials of -27 to -31 mV and mean particle size of 100 to 160 nm. After intravenous injection, S-35-labeled ODNs were eliminated rapidly from the circulation; however, their organ disposition characteristics depended on their type. Complex formation with glycosylated PLL increased the hepatic uptake and decreased the urinary clearance of these ODNs to a great extent. These complexes were taken up by both liver parenchymal cells (PC) and nonparenchymal cells (NPC). However, ODNs/Gal-PLL complexes showed a fairly high PC concentration, whereas ODNs/Man-PLL complexes distributed equally to both PC and NPC. The hepatic uptakes of PS/Gal-PLL and PS/Man-PLL complexes were partially inhibited by prior administration of Gal-BSA and Man-BSA, respectively, suggesting their hepatic uptake via the respective receptor-mediated endocytosis. However, uptake by galactose receptors of Kupffer cells, 5 potential, particle size, and Kupffer cell phagocytosis also seem to influence their uptake process. In conclusion, this study illustrates that ODNs can be delivered to hepatocytes and macrophages via galactose and mannose receptors, respectively. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 40 条
[1]   PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J].
AGRAWAL, S ;
TEMSAMANI, J ;
TANG, JY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7595-7599
[2]   INTERACTIONS OF ANTISENSE DNA OLIGONUCLEOTIDE ANALOGS WITH PHOSPHOLIPID-MEMBRANES (LIPOSOMES) [J].
AKHTAR, S ;
BASU, S ;
WICKSTROM, E ;
JULIANO, RL .
NUCLEIC ACIDS RESEARCH, 1991, 19 (20) :5551-5559
[3]   CARBOHYDRATE-SPECIFIC RECEPTORS OF THE LIVER [J].
ASHWELL, G ;
HARFORD, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 :531-554
[4]  
Bayever E, 1992, Antisense Res Dev, V2, P109
[5]  
BIESSEN EAL, 1995, CELL HEPATIC SINUSOI, V5, P358
[6]   DRUG TARGETING - SYNTHESIS AND ENDOCYTOSIS OF OLIGONUCLEOTIDE-NEOGLYCOPROTEIN CONJUGATES [J].
BONFILS, E ;
DEPIERREUX, C ;
MIDOUX, P ;
THUONG, NT ;
MONSIGNY, M ;
ROCHE, AC .
NUCLEIC ACIDS RESEARCH, 1992, 20 (17) :4621-4629
[7]  
CARMICHAEL EP, 1995, DELIVERY STRATEGIES, P267
[8]   INHIBITION OF LEUKEMIA-CELL PROLIFERATION BY FOLIC-ACID POLYLYSINE-MEDIATED INTRODUCTION OF C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES INTO HL-60 CELLS [J].
CITRO, G ;
SZCZYLIK, C ;
GINOBBI, P ;
ZUPI, G ;
CALABRETTA, B .
BRITISH JOURNAL OF CANCER, 1994, 69 (03) :463-467
[9]   INHIBITION OF LEUKEMIA-CELL PROLIFERATION BY RECEPTOR-MEDIATED UPTAKE OF C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
CITRO, G ;
PERROTTI, D ;
CUCCO, C ;
DAGNANO, I ;
SACCHI, A ;
ZUPI, G ;
CALABRETTA, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :7031-7035
[10]  
COSSUM PA, 1993, J PHARMACOL EXP THER, V267, P1181